相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Efficacy and Safety of Early Cyclosporine Conversion to Sirolimus with Continued MMF-Four-Year Results of the Postconcept Study
Y. Lebranchu et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2011)
The ORION Study: Comparison of Two Sirolimus-Based Regimens versus Tacrolimus and Mycophenolate Mofetil in Renal Allograft Recipients
S. M. Flechner et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2011)
Mycophenolate mofetil-based immunosuppression with sirolimus in renal transplantation: a randomized, controlled Spare-the-Nephron trial
Matthew R. Weir et al.
KIDNEY INTERNATIONAL (2011)
Everolimus-based, calcineurin-inhibitor-free regimen in recipients of de-novo kidney transplants: an open-label, randomised, controlled trial
Klemens Budde et al.
LANCET (2011)
mTOR inhibition: the learning curve in kidney transplantation
Matthew R. Weir et al.
TRANSPLANT INTERNATIONAL (2010)
Efficacy on Renal Function of Early Conversion from Cyclosporine to Sirolimus 3 Months After Renal Transplantation: Concept Study
Y. Lebranchu et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2009)
Inhibitors of the Mammalian Target of Rapamycin and Transplant Tolerance
Oriol Bestard et al.
TRANSPLANTATION (2009)
Conversion From Calcineurin Inhibitors to Sirolimus Maintenance Therapy in Renal Allograft Recipients: 24-Month Efficacy and Safety Results From the CONVERT Trial
Francesco P. Schena et al.
TRANSPLANTATION (2009)
A randomized, multicenter study of steroid avoidance, early steroid withdrawal or standard steroid therapy in kidney transplant recipients
F. Vincenti et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2008)
Long-term efficacy and safety of a calcineurin inhibitor-free regimen in live-donor renal transplant recipients
Ahmed F. Hamdy et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2008)
Immunosuppressive medications, clinical and metabolic parameters in new-onset diabetes mellitus after kidney transplantation
Melanie Roland et al.
TRANSPLANT INTERNATIONAL (2008)
Poor tolerance of sirolimus in a steroid avoidance regimen for renal transplantation
Matthew P. Welberry Smith et al.
TRANSPLANTATION (2008)
Reduced exposure to calcineurin inhibitors in renal transplantation
Henrik Ekberg et al.
NEW ENGLAND JOURNAL OF MEDICINE (2007)
Sirolimus versus cyclosporine in kidney recipients receiving Thymoglobulin®, mycophenolate mofetil and a 6-month course of steroids
M. Buechler et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2007)
Kidney transplantation with sirolimus and mycophenolate mofetil-based immunosuppression: 5-year results of a randomized prospective trial compared to calcineurin inhibitor drugs
Stuart M. Flechner et al.
TRANSPLANTATION (2007)
Sirolimus interferes with iron homeostasis in renal transplant recipients
Annamaria Maiorano et al.
TRANSPLANTATION (2006)
Tacrolimus combined with two different dosages of sirolimus in kidney transplantation:: Results of a multicenter study
S Vitko et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2006)
Complete avoidance of calcineurin inhibitors in renal transplantation: A randomized trial comparing sirolimus and tacrolimus
TS Larson et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2006)
Maintenance immunosuppression with target-of-rapamycin inhibitors is associated with a reduced incidence of de novo malignancies
HM Kauffman et al.
TRANSPLANTATION (2005)
Low incidence of malignancy among sirolimus/cyclosporine-treated renal transplant recipients
BD Kahan et al.
TRANSPLANTATION (2005)
Early low-grade proteinuria: Causes, short-term evolution and long-term consequences in renal transplantation
JM Halimi et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2005)
Two-year incidence of malignancy in sirolimus-treated renal transplant recipients: results from five multicenter studies
T Mathew et al.
CLINICAL TRANSPLANTATION (2004)
A randomized controlled trial of cyclosporine withdrawal in renal-transplant recipients: 15-year results
MP Gallagher et al.
TRANSPLANTATION (2004)
De novo kidney transplantation without use of calcineurin inhibitors preserves renal structure and function at two years
SM Flechner et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2004)
Predictors of success in conversion from calcineurin inhibitor to sirolimus in chronic allograft dysfunction
F Diekmann et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2004)
Randomized trial of tacrolimus in combination with sirolimus or mycophenolate mofetil in kidney transplantation: Results at 6 months
T Gonwa et al.
TRANSPLANTATION (2003)
Kidney transplantation without calcineurin inhibitor drugs: A prospective, randomized trial of sirolimus versus cyclosporin
SM Flechner et al.
TRANSPLANTATION (2002)
Sirolimus allows early cyclosporine withdrawal in renal transplantation resulting in improved renal function and lower blood pressure.
RWG Johnson et al.
TRANSPLANTATION (2001)
Outcome of cadaveric renal transplant patients treated for 10 years with cyclosporine -: Is chronic allograft nephropathy the major cause of late graft loss?
R Marcén et al.
TRANSPLANTATION (2001)
Sirolimus in association with mycophenolate mofetil induction for the prevention of acute graft rejection in renal allograft recipients
H Kreis et al.
TRANSPLANTATION (2000)
分享论文
